All
FDA Approves Tecentriq in Lung Cancer Subset
Tecentriq was approved by the U.S. Food and Drug Administration (FDA) for some patients with lung cancer.
Precision Clinical Trial Aims to Find First New Treatment for AML in More than 40 Years
The Beat AML trial just launched, and researchers are hoping it will find better treatment for patients with acute myeloid leukemia.
Ovarian Cancer Trial Stopped Due to Low Response
A trial testing Zytiga's effectiveness in ovarian cancer was recently halted.
After Cancer: The Beautiful Broken
Healing from breast cancer is difficult, but sometimes the changes are worthwhile.
Breast Cancer Diagnosis: 30 Years Later
LaTour clearly remembers the day of her diagnosis three decades ago.
Helping Children When a Family Member Has Cancer
Cancer and Finances
Innovators Take Home Prize Money for Developing Tools to Improve the Lives of Patients With Cancer
The three winners of an international competition were awarded grant money to further develop their innovations to better the lives of patients with cancer.
Computer Simulation Can Help Plan Brain Cancer Treatment
A computer simulation tool may help plan treatment for certain patients with recurrent glioblastoma.
Recovered
Recovery is an up-and-down process, and it's okay to show yourself compassion through the ups and the downs.
Pinking Responsibly During Breast Cancer Awareness Month
Know when that pink ribbon makes a difference (and when it doesn't).
Discussing PARP Inhibitors in Triple-Negative Breast Cancer
As the treatment paradigm shifts for triple-negative breast cancer, PARP inhibitors will continue to play a role.
Discovering New Patient Subsets Will Help Individualize Acute Lymphoblastic Leukemia Care
Subsets of patients with acute lymphoblastic leukemia are getting more personalized care.
Trial Data May Change Standard Second-Line Treatment of Liver Cancer
After doing well in a phase 3 trial, Stivarga showed the potential to shift the treatment paradigm for previously treated liver cancer.
Reliving a Cancer Diagnosis Through the Eyes of an Ultrasound
Scanxiety due to a scheduled or surprise scan or ultrasound can trigger those thoughts and fears of cancer recurrence at any moment.
In Their Own Words: Women Share in a Cancer Conversation
Women breast cancer survivors explain what they want to hear from the men in their lives.
Adjuvant Immunotherapy Agent Associated With Improved Survival in High-Risk Melanoma
Yervoy reduced risk of death for patients with high-risk stage 3 melanoma in a recent study.
Adding Immunotherapy to Standard Care Showed No Benefit for Head and Neck Cancer
The addition of immunotherapy did not show an improved progression-free survival for some patients with head and neck cancer.
New Drug Combination Benefits Subset of Patients With Melanoma
A new drug combination showed improved progression-free survival for patients with advanced melanoma, according to a recent study.
Expert Discusses Lynch-Like Syndrome in Rectal Cancer
Patients with DNA mismatch repair deficiency rectal cancer may not necessarily have Lynch syndrome. Expert Yi-Qian Nancy You weighs in on the topic.
A Cancer Survivor's Home Maintenance on Limited Energy
Cancer survivor rethinks her home for easier management after cancer.
Improving How Doctors and Patients Have Difficult Conversations
Active Surveillance Does Not Increase Stress Levels for Low-Risk Prostate Cancer Patients
Choosing active surveillance did not increase stress levels for men with low-risk prostate cancer, according to a recent study.
Expert Discusses What Advances to Expect in Liver Cancer
Michael Choti talks about what kind of advances can be expected in treating liver cancer, including PD-1 inhibitors and neoadjuvant treatment.
Neoadjuvant Therapy Shows Unexpected Benefit for High-Risk Soft Tissue Sarcoma
A recent trial presented an unexpected survival benefit for patients with high-risk soft tissue sarcoma who were on anthracycline-based neoadjuvant chemotherapy.
Cancer Caregiving: Perspective in Retrospect
Johnson writes about seeing clearly when the storm clouds settle.
National No Bra Day 2016: A Breast Cancer Survivor's Perspective
Not all breast cancer survivors support this social media campaign.
Immunotherapy Agent Falls Short Versus Chemotherapy in Lung Cancer
Findings from a recent trial show that frontline Opdivo did not improve progression-free survival over chemotherapy in certain patients with lung cancer.
Cabometyx Bests Sutent in Reducing Risk of Progression or Death in Metastatic Kidney Cancer
In a recent phase 2 trial, Cabometyx showed longer progression-free survival than Sutent in patients with metastatic kidney cancer.
Recent Event Brings Together Cancer Survivors, Patients, Caregivers and Medical Staff
Survivors and patients with cancer had the opportunity to celebrate alongside their friends, family and medical staff at a recent event in New Jersey.
